By proceeding, you agree to our Terms of Use and Privacy Policy.
About Stilla Technologies is a leading global biotechnology company that focuses on accelerating development of next-generation genetic testing by providing researchers and clinicians with a flexible Digital PCR solution for high-resolution genetic a
27-28 April 2022
As the precision medicine industry witnesses exciting Drug-Dx approvals being driven by major advancements in biomarker development, the 12th Clinical Biomarker & CDx Summit Europe returns in 2022 to set the stage for key learnings with exclusive dat
Event Ended
UK
Paid
London
26-29 September 2022
Marrying Complex Biomarker Validation & CDx Development for Supercharged Precision Oncology Pipeline Commercialization The 12th World Clinical Biomarkers & CDx Summit returns at a crucial time for the entire precision & targeted drug development indu
USA
Boston
11-14 October 2022
The European Society of Gene and Cell Therapy (ESGCT) promotes basic and clinical research in gene therapy, cell therapy, and genetic vaccines by facilitating education, the exchange of information and technology and by serving as a professional advi
Scotland
Edinburgh
16-17 November 2022
In the wake of new FDA guidance and exciting MRD partnership announcements between Grail & AstraZeneca, Amgen & Bristol Myers Squibb the liquid biopsy industry is experiencing a paradigm shift.
14-16 February 2023
Fast-Tracking Your Test Approvals & Reimbursement Path with Strategic Partnerships to Benefit Patients The 7th Liquid Biopsy for Precision Oncology Summit returns as the largest and most comprehensive forum for all stakeholders in the field to
San Diego